Vitamin C tied to better outcomes in precancerous blood disorders
New research links vitamin C supplements to improved outcomes by boosting TET enzymes, which regulate gene activity and are often impaired in blood cancers.
Clinical AI, drug discovery, devices, and regulatory approvals.
New research links vitamin C supplements to improved outcomes by boosting TET enzymes, which regulate gene activity and are often impaired in blood cancers.
New reporting examines the puzzle of why fear lingers long after the brain's initial danger alarm has fired.
The reality star's inflammatory condition underscores a potential link to esophageal cancer, a disease that killed her father.
Making AI chatbots more culturally sensitive does not guarantee safer mental health support, Canadian researchers caution.
Researchers identified a rare genetic change that appears to cause a previously unrecognized neurodevelopmental disorder, offering families a potential diagnosis.
A large study finds that the cardiovascular protection from GLP-1 medications fades within two years of stopping, leaving patients at higher risk of heart attack and stroke.
Cue Biopharma’s experimental hives treatment met its primary endpoint in a phase 2 study, positioning it as a potential challenger to Xolair.
A new emphasis on disease biology aims to capture the full heterogeneity of ALS alongside established measures like survival and ALSFRS-R.
A new AI framework could help clinicians spot advanced endometriosis more quickly, potentially reducing diagnostic delays.
A national survey shows that while many Australians with dementia report positive well-being, caregivers are often overwhelmed, with a third providing 70 hours of care.
New research suggests that rainwater tanks, a common water-saving measure in Australia, can contain potentially harmful bacteria and metals.
A new push toward precision medicine is replacing trial-and-error cancer treatment with therapies guided by the specific biology of each patient’s tumor.
New research suggests that mood deterioration after stopping antidepressants is more likely withdrawal than a return of the underlying condition.
Facing investor pressure, Novo Nordisk is betting on both its blockbuster obesity drugs and new pipeline areas to sustain growth.
New research suggests that tracking gut microbiome development could help predict type 1 diabetes in children at high genetic risk.
As cancer treatment shifts toward the home, supportive services are seen as just as vital as the medical care itself.
Fragmented patient data and poor care coordination quietly inflate medical spending, according to a new industry analysis.
A sponsored analysis from Healthcare Dive shows that the true expense of payment operations is spread across four separate budgets, making it difficult for health systems to measure and manage.